[Progress in combination therapy for invasive aspergillosis].
Ling
L
Luo
Email: tongzhh@hotmail.com.
Zhaohui
Z
Tong
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy* / Q000401:mortality; D001230:Aspergillus / Q000187:drug effects / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D054714:Echinocandins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D015996:Survival Rate; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*
D000935:Antifungal Agents; D054714:Echinocandins; D014230:Triazoles; D000666:Amphotericin B